Prevention of respiratory tract infections with bacterial lysate OM-85 bronchomunal in children and adults: A state of the art

Multidisciplinary Respiratory Medicine

Volumn 8, Issue 5, 2013, Pages

  De Benedetto, Fernando ^a   Sevieri, Gianfranco ^b  

^a Ss Annunziata Hospital   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Bacterial lysate; Chronic bronchitis; COPD; Immuno modulators; OM 85; Respiratory tract infections

Indexed keywords

BACTERIAL LYSATE OM 85; BACTERIUM LYSATE; UNCLASSIFIED DRUG;

CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT INFECTION; REVIEW; SYSTEMATIC REVIEW (TOPIC);

EID: 84879945289     PISSN: 1828695X     EISSN: 20496958     Source Type: Journal    
DOI: 10.1186/2049-6958-8-33     Document Type: Review

References (46)

1. Mäkelä MJ, Puhakka T, Ruuskanen O, Leinonen M, Saikku P, Kimpimäki M, Blomqvist S, Hyypiä T, Arstila P: Viruses and bacteria in the etiology of the common cold. J Clin Microbiol 1998, 36:539-542. (Pubitemid 28060326)
2. Williams BG, Gouws E, Boschi-Pinto C, Bryce J, Dye C: Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis 2002, 2:25-32. (Pubitemid 36109303)
3. Li JSM, Peat JK, Xuan W, Berry G: Meta-analysis on the association between environmental tobacco smoke (ETS) exposure and the prevalence of lower respiratory tract infection in early childhood. Pediatr Pulmonol 1999, 27:5-13. (Pubitemid 29063795)
4. Smith KR, Sarnet JM, Romieu I, Bruce N: Indoor air pollution in developing countries and acute lower respiratory infection in children. Thorax 2000, 55:518-532. (Pubitemid 30307271)
5. Oddy W, Sly P, de Klerk NH, Landau LI, Kendall GE, Holt PG, Stanley FJ: Breast feeding and respiratory morbidity in infancy: a birth cohort study. Arch Dis Child 2003, 88:224-228. (Pubitemid 36277683)
6. Kamper-Jørgensen M, Wohlfahrt J, Simonsen J, Grønbæk M, Stabell BC: Population-Based Study of the Impact of Childcare Attendance on Hospitalizations for Acute Respiratory Infections. Pediatrics 2006, 118:1439-1446. (Pubitemid 46393789)
7. Decramer M, Janssens W, Miravitilles M: Chronic obstructive pulmonary disease. Lancet 2012, 379:1341-1351.
8. Singanayagam A, Joshi PV, Mallia P, Johnston SL: Viruses exacerbating chronic pulmonary disease: the role of immune modulation. BMC Med 2012, 10:27.
9. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, Fabbri LM, Johnston SL: Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J RespirCrit Care Med 2006, 173:1114-1121. (Pubitemid 43726892)
10. Huber M, Mossmann M, Bessler WG: Th1-orientated immunological properties of the bacterial extract OM-85 BV. Eur J Med Res 2005, 10:209-217. (Pubitemid 40753851)
11. Rozy A, Chorostowska-Wynimko J: Bacterial immunostimulants - mechanism of action and clinical application in respiratory diseases. Pneumonol Alergol Pol 2008, 76:353-359.
12. Mauel J, Van Pham T, Kreis B, Bauer J: Stimulation by a bacterial extract (Broncho-Vaxom) of the metabolic and functional activities of murine macrophages. Int J Immunopharmacol 1989, 11:637-645. (Pubitemid 19239438)
13. Duchow J, Marchant A, Delville JP, Schandene L, Goldman M: Upregulation of adhesion molecules induced by Broncho-Vaxom® on phagocytic cells. Int J Immunopharmacol 1992, 14:761-766.
14. Bessler WG, Heinevetter L, Wiesmüller KH, Jung G, Baier W, Huber M, Lorenz AR, Esche UV, Mittenbühler K, Hoffmann P: Bacterial cell wall components as immunomodulators-I. Lipopeptides as adjuvants for parenteral and oral immunization. Int J Immunopharmacol 1997, 19:547-550. (Pubitemid 28261013)
15. Alyanakian MA, Grela F, Aumeunier A, Chiavaroli C, Gouarin C, Bardel E, Normier G, Chatenoud L, Thieblemont N, Bach JF: Transforming growth factor-beta and natural killer T-cells are involved in the protective effect of a bacterial extract on type 1 diabetes. Diabetes 2006, 55:179-185. (Pubitemid 43343313)
16. Navarro S, Cossalter G, Chiavaroli C, Kanda A, Fleury S, Lazzari A, Cazareth J, Sparwasser T, Dombrowicz D, Glaichenhaus N, Julia V: The oral administration of bacterial extracts prevents asthma via the recruitment of regulatory T cells to the airways. Mucosal Immunol 2011, 4:53-65.
17. Collet JP, Ducruet T, Kramer MS, Haggerty J, Floret D, Chomel JJ, Durr F, The Epicrèche Research Group: Stimulation of nonspecific immunity to reduce the risk of recurrent infections in children attending day-care centers. Pediatr Infect Dis J 1993, 12(8):648-652. (Pubitemid 23231160)
18. Jara-Pérez JV, Berber A: Primary prevention of acute respiratory tract infections in children using a bacterial immunostimulant: a double-masked, placebo-controlled clinical trial. Clin Ther 2000, 22:748-759. (Pubitemid 30451999)
19. Gutiérrez-Tarango MD, Berber A: Safety and efficacy of two courses of OM-85 BV in the prevention of respiratory tract infections in children during 12 months. Chest 2001, 119:1742-1748. (Pubitemid 32744931)
20. Schaad UB, Mütterlein R, Goffin H, BV-Child Study Group: Immunostimulation with OM-85 in children with recurrent infections of the upper respiratory tract: a double-blind, placebo-controlled multicenter study. Chest 2002, 122:2042-2049. (Pubitemid 36051142)
21. Holt PG, Sly PD: Prevention of allergic respiratory disease in infants: current aspects and future perspectives. Curr Opin Allergy Clin Immunol 2007, 7:547-555. (Pubitemid 350076452)
22. Razi CH, Harmanci K, Abaci A, Özdemir O, Hizli S, Renda R, Keskin F: The immunostimulant OM-85 BV prevents wheezing attacks in preschool children. J Allergy Clin Immunol 2010, 126:763-769.
23. Lusuardi M, Capelli A, Carli S, Sapada EL, Spinazzi A, Donner CF: Local Airways Immune Modifications Induced by Oral Bacterial Extracts in Chronic Bronchitis. Chest 1993, 103:1783-1791. (Pubitemid 23174315)
24. Cvoriscec B, Ustar M, Pardon R, Palecek I, Stipic-Markovic A, Zimic B: Oral immunotherapy of chronic bronchitis: a double-blind placebo-controlled multicentre study. Respiration 1989, 55(3):129-135. (Pubitemid 19203969)
25. Puigdollers JM, Serna GR, Hernández del Rey I, Barruffet MT, Torroella JJ: Immunoglobulin production in man stimulated by orally administered bacterial lysate. Respiration 1980, 40:142-149. (Pubitemid 11241285)
26. Del-Río-Navarro BE, Luis Sienra-Monge JJ, Berber A, Torres-Alcántara S, Avila-Castañón L, Gómez-Barreto D: Use of OM-85 BV in children suffering from recurrent respiratory tract infections and subnormal IgG subclass levels. Allergol Immunopathol (Madr) 2003, 31:7-13.
27. Karaca NE, Gulez N, Aksu G, Azarsiz E, Kutukculer N: Does OM-85 BV prophylaxis trigger autoimmunity in IgA deficient children? Int Immunopharmacol 2011, 11:1747-1751.
28. Steurer-Stey C, Bachmann LM, Steurer J, Tramèr MR: Oral purified bacterial extracts in chronic bronchitis and COPD: systematic review. Chest 2004, 126:1645-1655. (Pubitemid 39525042)
29. Schaad UB: OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review. World J Pediatr 2010, 6:5-12.
30. Del-Rio-Navarro BE, Espinosa Rosales F, Flenady V, Sienra-Monge JJ: Immunostimulants for preventing respiratory tract infection in children. Cochrane Database Syst Rev 2006, 4:CD004974.
31. Del-Rio-Navarro BE, Espinosa-Rosales FJ, Flenady V, Sienra-Mongen JJL: Immunostimulants for preventing respiratory tract infection in children. Evid Based Child Health 2012, 7:629- 717.
32. Del-Rio-Navarro BE, Blandon-Vigil V: Commentary on "Oral purified bacterial extracts in acute respiratory tract infections in childhood: a systematic review". Eur J Pediatr 2008, 167:121-122. (Pubitemid 350159815)
33. MiceliSopo S, Onesimo R, Giorgio V, Fundarò C, Tabacco F, Calvani M: Efficacy of over-the-counter immunostimulants in the prevention of paediatric recurrent acute respiratory tract infections. Criticisms and pitfalls of available metanalyses. Eur Ann Allergy ClinImmunol 2011, 43(5):157-161.
34. Russi EW, Leuenberger P, Brändli O, Frey JG, Grebski E, Gugger M, Paky A, Pons M, Karrer W, Kuhn M, Rochat T, Schibli R, Solèr M, Wacker J: Management of chronic obstructive pulmonary disease: the Swiss guidelines. Official Guidelines of the Swiss Respiratory Society: Swiss Med Wkly 2002, 132(5-6):67-78. (Pubitemid 34311008)
35. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2011. http://www.goldcopd.org/.
36. Orcel B, Delclaux B, Baud M, Derenne JP: Oral immunization with bacterial extracts for protection against acute bronchitis in elderly institutionalized patients with chronic bronchitis. Eur Respir J 1994, 7:446-452. (Pubitemid 24099003)
37. Collet JP, Shapiro P, Ernst P, Renzi T, Ducruet T, Robinson A: Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease.The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant. Am J Respir Crit Care Med 1997, 156:1719- 1724.
38. Li J, Zheng JP, Yuan JP, Zeng GQ, Zhong NS, Lin CY: Protective effect of a bacterial extract against acute exacerbation in patients with chronic bronchitis accompanied by chronic obstructive pulmonary disease. Chin Med J (Engl) 2004, 117:828-834. (Pubitemid 38961673)
39. Solèr M, Mütterlein R, Cozma G, Swiss-German OM-85 Study Group: Double-blind study of OM-85 in patients with chronic bronchitis or mild chronic obstructive pulmonary disease. Respiration 2007, 74:26-32. (Pubitemid 46012445)
40. Tang H, Fang Z, Xiu Q, on behalf of the Broncho-Vaxom Study Group (Shanghai, China): Efficacy and safety of bacterial lysates in patients with chronic obstructive pulmonary disease and exacerbation, ERS Annual Congress. 2011. Abstract number 3358.
41. Crothers K: Chronic obstructive pulmonary disease in patients who have HIV infection. Clin Chest Med 2007, 28:575-587.
42. Capetti A, Zucchi P, Landonio S, Terzi R, Argenteri B, Ricci E, Rizzardini G: Efficacy and tolerability of OM-85 BV in the prevention of seasonal respiratory infections in HIV-infected patients at high risk of recurrent events, XVIII International AIDS Conference. 2010. Abstract no. TUPE0097.
43. Sprenkle MD, Niewoehner DE, MacDonald R, Rutks I, Wilt TJ, COPD: Clinical efficacy of OM-85 BV in COPD and chronic bronchitis: a systematic review. COPD 2005, 2:167-175. (Pubitemid 40776238)
44. Zaniolo O, Pradelli L, Eandi M: Costo/efficaciadellaprevenzione di infezionialle prime vie aereemediante un estrattobattericoimmunostimolanteaspecifico (OM-85). Farmacoeconomia e percorsi terapeutici 2005, 6:169-184.
45. Weinberger M: Can we prevent exacerbations of asthma caused by common cold viruses? J Allergy Clin Immunol 2010, 126:770-771.
46. Weinberger M: Commentary on: 'Immunostimulants for preventing respiratory tract infection in children'. Evid Based Child Health 2012, 7:718-720.